NewAmsterdam Pharma (NAMS) Return on Sales (2023 - 2026)
NewAmsterdam Pharma (NAMS) posted Return on Sales of 0.16% for Q1 2026, up 99.32% sequentially from 23.41% in Q4 2025, and down 3.0% YoY from 0.16% in Q1 2025.
NewAmsterdam Pharma (NAMS) Return on Sales (2023 - 2026) Analysis & Trends
NewAmsterdam Pharma has reported Return on Sales for 4 years, with the latest figure at 0.16% in Q1 2026.
- Quarterly Return on Sales fell 3.0% year-over-year to 0.16% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.09% (down 5.0% YoY) and the FY2025 annual result came in at 0.07%, down 1.0% from the prior year.
- Return on Sales climbed to 0.16% in Q1 2026 per NAMS's latest filing, from 23.41% in the prior quarter.
- Over five years, Return on Sales peaked at 0.01% in Q3 2024 and troughed at 23.41% in Q4 2025.
- A 4-year average of 2.29% and a median of 0.16% in 2023 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2024 and 2025: Return on Sales surged 54 bps in 2024, then tumbled 2334 bps in 2025.
- Over 4 years, Return on Sales stood at 0.62% in 2023, then jumped by 88 bps to 0.07% in 2024, then slumped by 32342 bps to 23.41% in 2025, then jumped by 99 bps to 0.16% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.16%, 23.41%, and 2.07% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | NewAmsterdam Pharma | 3.17 Bn | 3.17 Bn | - | -0.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.17% |
| Mar 31, 2026 | -0.16% |
| Dec 31, 2025 | -23.41% |
| Sep 30, 2025 | -2.07% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.13% |
| Dec 31, 2024 | -0.07% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.17% |
| Mar 31, 2024 | -0.67% |
| Dec 31, 2023 | -0.62% |
| Sep 30, 2023 | -0.16% |
| Mar 31, 2023 | -0.05% |